Related Experiment Video
Updated: Jun 10, 2026

09:07
Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
Published on: August 22, 2019
Microselection--affinity selecting antibodies against a single rare cell in a heterogeneous population
Morten Draeby Sørensen1, Inge Errebo Agerholm, Britta Christensen
1Department of Molecular Biology, University of Aarhus, Aarhus, Denmark.
Journal of Cellular and Molecular Medicine
|August 24, 2010
Summary
This study introduces a microselection method for isolating rare cells, like circulating tumor cells, using antibody selection. The technique successfully identified specific K562 cells among millions of others for diagnostic applications.
Area of Science:
- Biotechnology
- Cell Biology
- Immunology
Background:
- Rare cells, such as circulating tumor cells (CTCs), are valuable for non-invasive diagnostics and monitoring.
- Effective isolation of rare cells from heterogeneous populations requires highly specific cell-type markers, typically antibodies.
Purpose of the Study:
- To develop a microselection method for antibody selection against single cells within a heterogeneous population.
- To enable the identification and isolation of rare cells for potential diagnostic applications.
Main Methods:
- A microselection technique utilizing phage display was developed for antibody selection.
- A single K562 cell (XX, female) was isolated among millions of lymphocytes (XY, male) on a glass slide.
- Phage bound to the target cell were protected, while unbound phages were inactivated by UV irradiation.
Main Results:
- The microselection method allowed for antibody selection targeting individual cells.
- Up to eight antibodies were retrieved per single cell selection.
- Three highly K562 cell type-specific antibodies were identified.
Conclusions:
- The developed microselection method is effective for isolating antibodies against specific single cells in complex mixtures.
- This technique holds promise for advancing non-invasive diagnostics through the capture of rare cells like CTCs.

